Eventos

Noticias

BVI crea el European Surgical Leadership Council y amplía su colaboración global con cirujanos

Posted on Wednesday May 6th, 2026

El consejo actuará como grupo asesor, proporcionando a BVI orientación sobre conocimiento del mercado, práctica clínica y formación quirúrgica en toda Europa.
La iniciativa se basa en el impulso generado por el Surgical Leadership Council de BVI en Estados Unidos, ampliando su modelo de colaboración a mercados europeos clave.

WALTHAM, Massachusetts, 6 de mayo de 2026 — BVI, compañía global especializada en dispositivos oftalmológicos, anunció hoy la creación de su European Surgical Leadership Council. El grupo está formado por siete cirujanos, figuras destacadas en sus respectivos campos, que representan las especialidades de segmento anterior, glaucoma y cirugía vitreorretiniana en mercados europeos clave. Leer más

BVI anuncia el marcado CE bajo el Reglamento Europeo de Productos Sanitarios (EU MDR) para Virtuoso, una nueva plataforma quirúrgica de doble funcionalidad

Posted on Monday April 20th, 2026

Obtención del marcado CE bajo el Reglamento Europeo de Productos Sanitarios (EU MDR) para Virtuoso®, la primera plataforma de facovitrectomía de doble funcionalidad de BVI, diseñada para ofrecer un nivel avanzado de control, eficiencia y versatilidad tanto en cirugía de cataratas como en cirugía vitreorretiniana.
El primer paciente fue tratado con éxito en el LMU Klinikum de Múnich, Alemania, en diciembre de 2025. Este hito se suma a la presencia de Virtuoso® en los principales congresos del sector celebrados en 2025, incluidos EURETINA, ESCRS y FloRETINA, y continuó en 2026 durante el Munich Retina Meeting, donde la plataforma participó en su primera cirugía en directo, reforzando su enfoque de diseño centrado en la estabilidad de fluidos, la eficiencia del flujo de trabajo y las necesidades reales de la cirugía oftalmológica.

BVI nombra a Jim Hollingshead presidente y director general

Posted on Tuesday January 20th, 2026

Waltham, MA., 19 de enero de 2026 - BVI, líder mundial en el mercado de dispositivos oftálmicos, ha anunciado hoy el nombramiento de Jim Hollingshead como presidente y director general (President & Chief Executive Officer). Hollingshead sucede a Shervin Korangy, que continuará como asesor de BVI y comenzará una nueva función como asesor principal de TPG Capital. Leer más

BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures

Posted on Wednesday September 3rd, 2025

BVI announces Virtuoso®, its first dual-function phaco-vitrectomy system designed to deliver advanced control, efficiency, and versatility for both cataract and vitreoretinal surgery.
European debut planned for 2025 Global ophthalmic congresses in Europe (Euretina and ESCRS).

Waltham, Mass., September 3, 2025 – BVI, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the European market unveiling of its innovative phaco-vitrectomy surgical platform, Virtuoso®, a dual-function system designed for both cataract and vitreoretinal procedures. Leer más

BVI Recognized for Breakthrough Innovation, Strategic Growth, and Product Launches in 2025, Marking a Landmark Year in Eye Care Advancement

Posted on Wednesday July 9th, 2025

BVI received four awards in the 2025 Medical Device Network Excellence Awards—for Innovation, Product Launches, R&D, and Investments—recognizing its leadership in advancing ophthalmic technology and global growth.
Key achievements include the launch of SERENITY IOLs with ISOFOCAL technology, FDA clearance of the Leos™ glaucoma system, and a $1 billion capital raise supporting strategic expansion and continued innovation.

WALTHAM, Mass., July 9th, 2025 – BVI, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, has been recognized with four prestigious accolades in the 2025 Medical Device Network Excellence Awards. The company earned top honors in Innovation, Research and Development, Investments, and Product Launches, underscoring its leadership in advancing eye care technology, strategic growth, and breakthrough product development. Leer más

Ver más eventos

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_UA-142478797-1	1 minute	A variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gcl_au	3 months	Provided by Google Tag Manager to experiment advertisement efficiency of websites using their services.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress	30 minutes	Hotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen	30 minutes	Hotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample	2 minutes	Hotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjTLDTest	session	To determine the most generic cookie path that has to be used instead of the page hostname, Hotjar sets the _hjTLDTest cookie to store different URL substring alternatives until it fails.
BrowserId	1 year	This cookie is used for registering a unique ID that identifies the type of browser. It helps in identifying the visitor device on their revisit.
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
vuid	2 years	Vimeo installs this cookie to collect tracking information by setting a unique ID to embed videos to the website.

Cookie	Duration	Description
_fbp	3 months	This cookie is set by Facebook to display advertisements when either on Facebook or on a digital platform powered by Facebook advertising, after visiting the website.
fr	3 months	Facebook sets this cookie to show relevant advertisements to users by tracking user behaviour across the web, on sites that have Facebook pixel or Facebook social plugin.
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.

Choose your country

Noticias y eventos

Eventos

Noticias

BVI crea el European Surgical Leadership Council y amplía su colaboración global con cirujanos

BVI anuncia el marcado CE bajo el Reglamento Europeo de Productos Sanitarios (EU MDR) para Virtuoso, una nueva plataforma quirúrgica de doble funcionalidad

BVI nombra a Jim Hollingshead presidente y director general

BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures

BVI Recognized for Breakthrough Innovation, Strategic Growth, and Product Launches in 2025, Marking a Landmark Year in Eye Care Advancement

Choose your country

Noticias y eventos

Página de inicio / Noticias & Eventos

Eventos

Noticias